Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AETHLON MEDICAL INC Director's Dealing 2013

Jul 15, 2013

35398_dirs_2013-07-15_fc43b633-b15b-445e-9da4-766d171a5717.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AETHLON MEDICAL INC (AEMD)
CIK: 0000882291
Period of Report: 2013-07-09

Reporting Person: Ward Phillip A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-07-09 10% Convertible Note $0.088 A Acquired 2013-10-09 Common Stock (3465909) Indirect

Footnotes

F1: Unpaid principal and accrued interest on the note are convertible at Mr. Ward's option into common stock only if the note is not repaid by October 9, 2013. In that event, unpaid principal and accrued interest may be converted into common stock at $0.088/share. In addition, upon conversion of the note, Mr. Ward would receive warrants to purchase that number of shares of common stock equal to 50% of the amount of principal and interest being converted divided by $0.088, with such warrants being exercisable at a price of $0.132/share.

F2: Maturity date.